Replies to post #305684 on Anavex Life Sciences Corp (AVXL)

[blue finch]

Personally I think the guy is a jerk
No clue

And his conversation with Cm was about banking not medical science

His comments to me over and over that 2-73 won’t work are based on zero knowledge

That’s what Wall Street is in many cases

I’ll stay the course

HF

[boi568]

"Nothing has ever worked and if it's going to happen it will be done by a big pharma" is not an impressive argument. I doubt this guy has any understanding of why BP has failed and why 2-73 is fundamentally different.

[falconer66a]

Pretty typical. We know better.

I asked him why. His reply was because nothing has ever worked and if it’s going to happen it will be done by a big pharma

This response to a query about the viability of Anavex, by an experienced stock investor professional is typical. That view is held by the vast majority of investment professionals who give a short once-over check of Anavex. They know better. No tiny young start-up company can possibly match or beat what all of the big pharmas have been trying to do for half a century: come up with a drug that treats Alzheimer's.

As mentioned — and well known — the billions of dollars the big pharmas have poured into Alzheimer's drug research have all failed. The real issue for them was the gigantic amounts of money that could be made by serving the Alzheimer's patient market. In fact, no one is going to find a cure for Alzheimer's. It's doubtful that blarcamesine will do that. In probably all cases of Alzheimer's a working drug will have to be taken for the rest of a patient's life; continuing big revenues to the drug company. The big pharmas have missed out on that. They aren't pleased.

And both physicians and investment advisor professionals, uninformed about Anavex biology, are certain that Anavex is but a hopeless shot in the distant darkness of Alzheimer's dementia. Big pharmas couldn't hit anything. Anavex won't, either, they are certain.

Such are the perceptions today. Rather useless to argue or provide any information to those certain of Anavex's failure. They know. They are smarter than we blokes posting stuff on this message board.

But, won't it be interesting, even great fun, to see what these smart Anavex naysayers will be saying when it is announced that blarcamesine provided profound therapeutic outcomes for girls with Rett syndrome? Even better, will be their enlightened pronouncements when the FDA promptly approves blarcamesine for Rett.

Then, it will be Alzheimer's itself, when the big clinical study concludes. From all the experts formerly warning us of Anavex's eventual failure, there will be a fridge silence.

No matter. Multitudes of patients suffering from several CNS diseases will then have hope. Anavex Life Sciences Corp will be a major, even global pharmaceutical firm; with several other pipeline drugs in new clinical trials for an even wider variety of diseases.

Lastly, and eventually (I prognosticate), blarcamesine will be taken by virtually everyone, starting at the age of 50, to prevent a diversity of geriatric debilities. Even more medically and socially significant than antibiotics in the 2th century.

[Bourbon_on_my_cornflakes]

SOUR GRAPES: He knows CM for many years before anavex and spoke to him recently. But it didnt go anywhere ( as far as raising money for anavex needs)

gee, an I-banker who failed to get a fee...poor baby. he wouldn't dream about bad-mouthing a company now would he?

[Bourbon_on_my_cornflakes]

Evidence proves: His reply was because nothing has ever worked and if it’s going to happen it will be done by a big pharma

yes, just like:

if electric vehicles will ever catch on, it will be done by GM (chevy volt) and not Tesla...

if personal computers/software ever catch on, it will be done by IBM, and not some people operating out of their garage at Apple or Microsoft...

if a paperless office ever catches on, it will be done by Xerox, and not some people operating out of their garage at Apple...

[Amatuer17]

Despite what is being said - his reaction and advice is valid and can still come true.

AD is tough disease and a lot of companies go close but not close enough.

So a good approach is to book some profit at right level and wait for opportunity to buy again. If you look, AVXL has given opportunity to enter again at lower price.
The results for AD are not in near future - also if the results are good to gray, you may lose the immediate bump but can buy the stock with much less risk and still make more money.

My few in-out in the stock has made me good money and my current holding is at zero cost and already booked more profit.